Supriya Lifescience Ltd reports 213% jump in Net Profit in Q3FY24 EBITDA zooms 195%

Supriya Lifescience Ltd has announced its unaudited financial results for the third quarter of FY24, reporting a remarkable growth in revenue, gross profit, EBITDA and PAT. The company's revenue increased by 33.2% YoY to Rs. 140.07 crore, while its gross profit grew by 59% to Rs. 85.45 crore. EBITDA almost tripled to reach Rs. 41.49 crore, with an EBITDA margin of 29.6%. PAT more than tripled to Rs. 29.79 crore, up 213% YoY.,